Body adiposity indicators and cardiometabolic risk : Cross-sectional analysis in participants from the PREDIMED-Plus trial

Copyright © 2018 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved..

BACKGROUND & AIMS: Excess adiposity is associated with poor cardiometabolic (CM) health. To date, several techniques and indicators have been developed to determine adiposity. We aimed to compare the ability of traditional anthropometric, as well as standard and novel DXA-derived parameters related to overall and regional adiposity, to evaluate CM risk.

METHODS: Using the cross-sectional design in the context of the PREDIMED-Plus trial, 1207 Caucasian senior men and women with overweight/obesity and metabolic syndrome (MetS) were assessed. At baseline, anthropometry- and DXA-measured parameters of central, visceral, peripheral and central-to-peripheral adiposity together with comprehensive set of CM risk factors were obtained. Partial correlations and areas under the ROC curve (AUC) were estimated to compare each adiposity measure with CM risk parameters, separately for men and women, and in the overall sample.

RESULTS: DXA-derived indicators, other than percentage of total body fat, showed stronger correlations (rho -0.172 to 0.206, p < 0.001) with CM risk than anthropometric indicators, after controlling for age, diabetes and medication use. In both sexes, DXA-derived visceral adipose tissue measures (VAT, VAT/Total fat, visceral-to-subcutaneous fat) together with lipodystrophy indicators (Trunk/Legs fat and Android/Gynoid fat) were strongly and positively correlated (p < 0.001) with glycated hemoglobin (HbA1c), the triglyceride and glucose index (TyG), triglycerides (TG), the ratio TG/HDL-cholesterol (TG/HDL-C), and were inversely related to HDL-C levels (p < 0.001). Furthermore, in AUC analyses for both sexes, VAT/Total fat showed the highest predictive ability for abnormal HbA1c levels (AUC = 0.629), VAT for TyG (AUC = 0.626), both lipodystrophy indicators for TG (AUCs = 0.556), and Trunk/Legs fat for HDL-C (AUC = 0.556) and TG/HDL-C (AUC = 0.581).

CONCLUSIONS: DXA regional adiposity measures offer advantages beyond traditional anthropometric and DXA overall adiposity indicators for CM risk assessment in senior overweight/obese subjects with MetS. In particular, in both sexes, visceral adiposity better stratifies individuals at risk for glucose abnormalities, and indicators of lipodystrophy better predict markers of dyslipidemia.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:38

Enthalten in:

Clinical nutrition (Edinburgh, Scotland) - 38(2019), 4 vom: 07. Aug., Seite 1883-1891

Sprache:

Englisch

Beteiligte Personen:

Konieczna, Jadwiga [VerfasserIn]
Abete, Itziar [VerfasserIn]
Galmés, Aina M [VerfasserIn]
Babio, Nancy [VerfasserIn]
Colom, Antoni [VerfasserIn]
Zulet, Maria Angeles [VerfasserIn]
Estruch, Ramón [VerfasserIn]
Vidal, Josep [VerfasserIn]
Toledo, Estefanía [VerfasserIn]
Díaz-López, Andrés [VerfasserIn]
Fiol, Miguel [VerfasserIn]
Casas, Rosa [VerfasserIn]
Vera, Josep [VerfasserIn]
Buil-Cosiales, Pilar [VerfasserIn]
Martín, Vicente [VerfasserIn]
Goday, Albert [VerfasserIn]
Salas-Salvadó, Jordi [VerfasserIn]
Martínez, J Alfredo [VerfasserIn]
Romaguera, Dora [VerfasserIn]
PREDIMED-Plus Investigators [VerfasserIn]

Links:

Volltext

Themen:

Adiposity indicators
Cardiometabolic risk
Dual-energy x-ray absorptiometry
Journal Article
Lipodystrophy indicators
PREDIMED-Plus trial
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Visceral adipose tissue

Anmerkungen:

Date Completed 02.09.2020

Date Revised 02.09.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.clnu.2018.07.005

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM286720744